After breakout year, Moderna on track to generate $15B+ in 2022 thanks to more demand, higher prices: analysts
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
June 4, 2021 at 12:00PM
After breakout year, Moderna on track to generate $15B+ in 2022 thanks to more demand, higher prices: analysts
Welcome to vaccine education 